NCT02184156View on ClinicalTrials.gov

A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL

4 mL injection of Ampion

4 mL injection of Ampion

DRUG

4 mL injection of Placebo

Trial Locations (1)

80112

Ampio Pharmaceuticals, Englewood

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT02184156 - A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain | Biotech Hunter | Biotech Hunter